Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 Legal status  




2 See also  




3 References  













JWH-203






●Polski
 ●Русский
 ●Српски / srpski
 ●Srpskohrvatski / српскохрватски
  
Edit links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

JWH-203
Legal status
Legal status
  • DE: Anlage II (Authorized trade only, not prescriptible)
  • UK: Class B
  • US: Schedule I
  • I-N (Poland)[1]
    • Identifiers

    • 2-(2-Chlorophenyl)-1-(1-pentylindol-3-yl)ethanone

    CAS Number
    PubChem CID
    ChemSpider
    UNII
    CompTox Dashboard (EPA)
    ECHA InfoCard100.233.381 Edit this at Wikidata
    Chemical and physical data
    FormulaC21H22ClNO
    Molar mass339.86 g·mol−1
    3D model (JSmol)

    • Clc2ccccc2CC(=O)c1cn(CCCCC)c3ccccc13

    • InChI=1S/C21H22ClNO/c1-2-3-8-13-23-15-18(17-10-5-7-12-20(17)23)21(24)14-16-9-4-6-11-19(16)22/h4-7,9-12,15H,2-3,8,13-14H2,1H3

    • Key:YDINKDBAZJOSLV-UHFFFAOYSA-N

      (verify)

    JWH-203 (1-pentyl-3-(2-chlorophenylacetyl)indole) is an analgesic chemical from the phenylacetylindole family that acts as a cannabinoid agonist with approximately equal affinity at both the CB1 and CB2 receptors, having a Ki of 8.0 nM at CB1 and 7.0 nM at CB2. It was originally discovered by, and named after, John W. Huffman, but has subsequently been sold without his permission as an ingredient of synthetic cannabis smoking blends.[2] Similar to the related 2'-methoxy compound JWH-250, the 2'-bromo compound JWH-249, and the 2'-methyl compound JWH-251, JWH-203 has a phenylacetyl group in place of the naphthoyl ring used in most aminoalkylindole cannabinoid compounds, and has the strongest in vitro binding affinity for the cannabinoid receptors of any compound in the phenylacetyl group.[3][4][5]

    Unexpectedly despite its weaker CB1Ki in vitro, the 2-methylindole derivative JWH-204 is actually more potent than JWH-203 in animal tests for cannabinoid activity, though it is still weaker than JWH-249.[6]

    JWH-204

    Legal status[edit]

    In the United States, JWH-203 is a Schedule I Controlled Substance.[7]

    As of October 2015, JWH-203 is a controlled substance in China.[8]

    See also[edit]

    References[edit]

    1. ^ "Ustawa z dnia 15 kwietnia 2011 r. o zmianie ustawy o przeciwdziałaniu narkomanii ( Dz.U. 2011 nr 105 poz. 614 )". Internetowy System Aktów Prawnych. Retrieved 17 June 2011.
  • ^ Bononi M, Belgi P, Tateo F (July 2011). "Analytical data for identification of the Cannabimimetic Phenylacetylindole JWH-203" (PDF). Journal of Analytical Toxicology. 35 (6): 360–3. doi:10.1093/anatox/35.6.360. PMID 21740693.
  • ^ Huffman JW, Szklennik PV, Almond A, Bushell K, Selley DE, He H, et al. (September 2005). "1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles". Bioorganic & Medicinal Chemistry Letters. 15 (18): 4110–3. doi:10.1016/j.bmcl.2005.06.008. PMID 16005223.
  • ^ Manera C, Tuccinardi T, Martinelli A (April 2008). "Indoles and related compounds as cannabinoid ligands". Mini Reviews in Medicinal Chemistry. 8 (4): 370–87. doi:10.2174/138955708783955935. PMID 18473928.
  • ^ Bononi M, Belgi P, Tateo F (July 2011). "Analytical data for identification of the Cannabimimetic Phenylacetylindole JWH-203" (PDF). Journal of Analytical Toxicology. 35 (6): 360–3. doi:10.1093/anatox/35.6.360. PMID 21740693.
  • ^ Wiley JL, Marusich JA, Martin BR, Huffman JW (June 2012). "1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice". Drug and Alcohol Dependence. 123 (1–3): 148–53. doi:10.1016/j.drugalcdep.2011.11.001. PMC 3294131. PMID 22127210.
  • ^ "Controlled Substances" (PDF). Drug Enforcement Administration.
  • ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.


    • Retrieved from "https://en.wikipedia.org/w/index.php?title=JWH-203&oldid=1205999405"
    Categories: 
    ●JWH cannabinoids
     ●Phenylacetylindoles
     ●Chloroarenes
     ●Designer drugs
     ●CB1 receptor agonists
     ●CB2 receptor agonists
     Hidden categories: 
    ●CS1 Chinese-language sources (zh)
     ●Articles with short description
     ●Short description matches Wikidata
     ●Drugs with non-standard legal status
     ●ECHA InfoCard ID from Wikidata
     ●Articles without EBI source
     ●Chemical pages without DrugBank identifier
     ●Articles without KEGG source
     ●Drugs missing an ATC code
     ●Use dmy dates from August 2019
      


    ●This page was last edited on 10 February 2024, at 23:51 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki